LIVE Webinar
Monday, December 6, 2021
3:00 - 4:30 PM Eastern Time
Early cancer detection is a key determinant of patient survival, but scientists struggle to identify reliable biomarkers and diagnostic tools. Researchers recently discovered cancer-specific glycosylation signatures that promote tumor progression. Because protein glycosylation controls cellular behaviors such as cell adhesion and migration, altered glycosylation states render cancer cells more invasive. In this webinar, brought to you by Vector Laboratories, Karen Abbott and Susan Bellis will discuss how cancer cells modify glycosylation pathways to survive, and how to target tumor-specific glycans for early cancer detection, prognosis, and therapeutic development.
Topics to be covered
Meet the Speakers:
Karen Abbott, PhD
Associate Professor
Department of Translational Medicine
Herbert Wertheim College of Medicine
Florida International University
Susan L. Bellis, PhD
Professor
Department of Cell, Developmental, and Integrative Biology
University of Alabama at Birmingham
Sponsored By
